tiprankstipranks
Jasper Therapeutics (JSPR)
NASDAQ:JSPR
US Market
JSPR
Jasper Therapeutics
RESEARCH TOOLSreports
Want to see JSPR full AI Analyst Report?

Jasper Therapeutics (JSPR) Stock News & Sentiment

1,059 Followers
Jasper Therapeutics Announces Board Resignation and Committee Change
Premium
Company Announcements
Jasper Therapeutics Announces Board Resignation and Committee Change
27m ago
8K
JSPR
Cisco, Arista, Jasper, StoneCo, Lisata Trending With Analysts
Premium
Weekend Updates
Cisco, Arista, Jasper, StoneCo, Lisata Trending With Analysts
6d ago
ANET
CSCO
Jasper Therapeutics’ Deep Cuts May Backfire: Analyst Warns Downsizing Could Undermine Briquilimab Strategy and Cash Runway
Premium
Company Announcements
Jasper Therapeutics’ Deep Cuts May Backfire: Analyst Warns Downsizing Could Undermine Briquilimab Strategy and Cash Runway
2M ago
JSPR
Buy Rating on Jasper: Briquilimab’s Strong CSU Efficacy, Favorable Safety, and Competitive Profile Underpin Key Near‑Term Value Driver
Premium
Ratings
Buy Rating on Jasper: Briquilimab’s Strong CSU Efficacy, Favorable Safety, and Competitive Profile Underpin Key Near‑Term Value Driver
2M ago
JSPR
Jasper Therapeutics, Inc. (JSPR) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Jasper Therapeutics, Inc. (JSPR) Q4 Earnings Cheat Sheet
2M ago
JSPR
Briquilimab’s Robust Efficacy and Favorable Safety in Urticaria Indicate Strong Upside for Jasper Therapeutics and Support a Buy Rating
Premium
Ratings
Briquilimab’s Robust Efficacy and Favorable Safety in Urticaria Indicate Strong Upside for Jasper Therapeutics and Support a Buy Rating
4M ago
JSPR
Jasper Therapeutics Reports Strong Briquilimab Data in Urticaria
Premium
Company Announcements
Jasper Therapeutics Reports Strong Briquilimab Data in Urticaria
4M ago
8K
JSPR
More JSPR News >

JSPR News on the Web

Cisco, Arista, Jasper, StoneCo, Lisata Trending With Analysts
TipRanks News
Bearish
Jasper Therapeutics price target lowered to $3 from $4 at RBC Capital
TipRanks News
Bearish
Analysts Have Conflicting Sentiments on These Healthcare Companies: Keros Therapeutics (KROS), Jasper Therapeutics (JSPR) and Corvus Pharmaceuticals (CRVS)
TipRanks News
Neutral
Jasper Therapeutics downgraded to Hold from Buy at TD Cowen
TipRanks News
Bearish
Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (OtherSEMHF), Tarsus Pharmaceuticals (TARS) and Jasper Therapeutics (JSPR)
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Jasper Therapeutics (JSPR), Alto Neuroscience, Inc. (ANRO) and Viridian Therapeutics (VRDN)
TipRanks News
Neutral
Jasper Therapeutics price target lowered to $7 from $12 at Evercore ISI
TipRanks News
Bearish
Jasper Therapeutics’ Deep Cuts May Backfire: Analyst Warns Downsizing Could Undermine Briquilimab Strategy and Cash Runway
TipRanks News
Bearish

News Score - Last 7 Days

Very Negative
JSPR
Sector Average
Media Buzz
This Week5 articles
Weekly Average0 articles
News Sentiment
This Week0%
Sector Average77%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is JSPR’s Media Buzz Sentiment?
Currently, no data Available
What is JSPR’s weekly average amount of articles?
Currently, no data Available
What is JSPR’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
RLAYRelay Therapeutics
GOSSGossamer Bio
IMVTImmunovant
ROIVRoivant Sciences
PROKProKidney
Showing the stocks with the most bullish news sentiment over the past week